Phosphorus as an early predictive factor in patients with acute liver failure

Transplantation

Volumn 75, Issue 12, 2003, Pages 2007-2014

  Baquerizo, Angeles ^a,d   Anselmo, Dean ^a   Shackleton, Christopher ^c   Chen, Teng wei ^a   Cao, Carlos ^a   Weaver, Michael ^a   Gornbein, Jeffrey ^b   Geevarghese, Sunil ^a   Nissen, Nicholas ^c   Farmer, Douglas ^a   Demetriou, Achilles ^d   Busuttil, Ronald W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ctr for Liver Dis/Transplantation   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; PHOSPHORUS; BIOLOGICAL MARKER; PHOSPHATE;

ADOLESCENT; ADULT; AGED; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CHILD; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RACE DIFFERENCE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; FOLLOW UP; HYPOPHOSPHATEMIA; LIVER TRANSPLANTATION; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; RACE; RETROSPECTIVE STUDY; SURVIVAL; TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CONTINENTAL POPULATION GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHOSPHATEMIA; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PHOSPHATES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0038789160     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000063219.21313.32     Document Type: Conference Paper

References (31)

1. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
2. Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997; 225: 484-491.
3. Strain AJ, Neuberger JM. A bioartificial liver-state of the art. Science 2002; 295: 1005-1009.
4. Brems JJ, Hiatt JR, Ramming KP, et al. Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg 1987; 154: 137-141.
5. Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109-119.
6. Emond JC, Aran PP, Whitington PF, et al. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583-1588.
7. Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis. J Gastroenterol Hepatol 1991; 6: 159-164.
8. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34.
9. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-66.
10. Fausto N. Liver regeneration. J Hepatol 2000; 32: 19-31.
11. Fujita M, Furukawa H, Hattori M, et al. Sequential observation of liver cell regeneration after massive hepatic necrosis in auxiliary partial orthotopic liver transplantation. Mod Pathol 2000; 13: 152-157.
12. Mann DV, Lam WW, Hjelm NM, et al. Metabolic control patterns in acute phase and regenerating human liver determined in vivo by 31-phosphorus magnetic resonance spectroscopy. Ann Surg 2002; 235: 408-416.
13. Pomposelli JJ, Pomfret EA, Burns DL, et al. Life-threatening hypophosphatemia after right hepatic lobectomy for live donor adult liver transplantation. Liver Transpl 2001; 7: 637-642.
14. George R, Shiu MH. Hypophosphatemia after major hepatic resection. Surgery 1992; 111: 281-286.
15. Fisher B, Szuch P, Fisher ER. Evaluation of a humoral factor in liver regeneration utilizing liver transplants. Cancer Res 1971; 31: 322-331.
16. Pomfret EA, Pomposelli JJ, Lewis WD, et al. Live donor adult liver transplantation using right lobe grafts: donor evaluation and surgical outcome. Arch Surg 2001; 136: 425-433.
17. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6: 648-651.
18. Castells A, Salmeron JM, Navasa M, et al. Liver transplantation for acute liver failure: analysis of applicability. Gastroenterology 1993; 105: 532-538.
19. Harrison PM, O'Grady JG, Keays RT, et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990; 301: 964-966.
20. Van Thiel DH, Udani M, Schade RR, et al. Prognostic value of thyroid hormone levels in patients evaluated for liver transplantation. Hepatology 1985; 5: 862-866.
21. Pereira LM, Langley PG, Hayllar KM, et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 1992; 33: 98-102.
22. Dawson DJ, Babbs C, Warnes TW, et al. Hypophosphataemia in acute liver failure. BMJ (Clin Res Ed) 1987; 295: 1312-1313.
23. Davenport A, Will EJ. Hypophosphataemia in acute liver failure. BMJ (Clin Res Ed) 1988; 296: 131.
24. Nanji AA, Anderson FH. Acute liver failure: a possible consequence of severe hypophosphatemia. J Clin Gastroenterol 1985; 7: 338-340.
25. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-298.
26. Segal MR. Regression trees for censored data. Biometrics 1988; 44: 35-47.
27. Forsstrom JJ, Dalton KJ. Artificial neural networks for decision support in clinical medicine. Ann Med 1995; 27: 509-517.
28. Subramanian R, Khardori R. Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 2000; 79: 1-8.
29. Lee WM, Galbraith RM, Watt GH, et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 1995; 21: 101-105.
30. Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163-169.
31. O'Grady JG, Gimson AE, O'Brien CJ, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-1192.